ZBH insider trading

NYSE Healthcare

ZIMMER BIOMET HOLDINGS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
597
Last 90 days
113
Buys / sells
6% / 11%
Market cap
$19.91B

About ZIMMER BIOMET HOLDINGS, INC.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Company website: www.zimmerbiomet.com

ZBH insider activity at a glance

FilingIQ has scored 597 insider transactions for ZBH since Jun 24, 2015. The most recent filing in our index is dated May 1, 2026.

Across the full history, 34 open-market purchases and 68 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ZBH insider trades is 60.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ZBH Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading ZBH

13F funds holding ZBH

Frequently asked

How many insider trades does FilingIQ track for ZBH?
FilingIQ tracks 597 Form 4 insider transactions for ZBH (ZIMMER BIOMET HOLDINGS, INC.), covering filings from Jun 24, 2015 onwards. 113 of those were filed in the last 90 days.
Are ZBH insiders net buyers or net sellers?
Across the full Form 4 history for ZBH, 34 transactions (6%) were open-market purchases and 68 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ZBH insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ZBH in?
ZIMMER BIOMET HOLDINGS, INC. (ZBH) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $19.91B.

Methodology & sources

Every ZBH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.